These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7525155)

  • 41. Testing for HCV markers.
    Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
    Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C infection in liver transplant patients.
    McCaughan GW; Pau A; Parsons C; McGuinness PH; Gallagher ND; Sheil AG
    Transplant Proc; 1992 Oct; 24(5):2256. PubMed ID: 1384207
    [No Abstract]   [Full Text] [Related]  

  • 43. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
    Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
    Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hepatitis C virus and transfusion: policy regarding the donation and the donor. Groupe "Hépatites Virales" de la Société Nationale de Transfusion Sanguine].
    Moncharmont P; Janot C; Boudart D; Cotte C; Couroucé AM; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):205-10. PubMed ID: 1329793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post-transfusion hepatitis.
    Ebeling F; Leikola J
    Ann Med; 1991 Oct; 23(4):361-6. PubMed ID: 1657047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C virus infection from blood and blood products.
    van der Poel CL
    FEMS Microbiol Rev; 1994 Jul; 14(3):241-6. PubMed ID: 7522022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test.
    Mattsson L; Grillner L; Weiland O
    Scand J Infect Dis; 1992; 24(1):15-20. PubMed ID: 1375390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-A, non-B hepatitis and the anti-HCV assay.
    Barbara JA; Contreras M
    Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 51. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
    León P; Echevarría JM
    Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
    [No Abstract]   [Full Text] [Related]  

  • 53. [European Acute Transfusion Hepatitis Interferon Study (EATHIS)].
    Jullien AM; Dejean AM; Janot C; Trepo C
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):199-204. PubMed ID: 1329792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group.
    Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity.
    Mutimer DJ; Harrison RF; O'Donnell KB; Shaw J; Martin BA; Atrah H; Ala FA; Skidmore S; Hubscher SG; Neuberger JM
    BMJ; 1994 Oct; 309(6958):847-8. PubMed ID: 7524875
    [No Abstract]   [Full Text] [Related]  

  • 58. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
    Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
    Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of screening and complementary tests for anti-HCV antibodies].
    Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
    Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission.
    Watanabe M; Ohkoshi S; Tawaraya H; Miyajima T; Shimotohno K; Kamimura T; Asakura H
    Transfusion; 1994 Feb; 34(2):125-9. PubMed ID: 7508643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.